US 7569729
Stable atomoxetine hydrochloride, a process for the preparation thereof, and an analytical control of its stability
granted A61PA61P25/18
Quick answer
US patent 7569729 (Stable atomoxetine hydrochloride, a process for the preparation thereof, and an analytical control of its stability) held by Teva Pharmaceutical Fine Chemicals S.R.L. expires Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Teva Pharmaceutical Fine Chemicals S.R.L.
- Grant date
- Tue Aug 04 2009 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 30 2029 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 26
- CPC classes
- A61P, A61P25/18